McNally Beth, Linder Mark, Valdes Roland
PGXL Laboratories, Louisville, KY 40202, USA.
Department of Pathology & Laboratory Medicine, University of Louisville School of Medicine, MDR Building, 511 S Flloyd Street, Room 222, Louisville KY 40292, USA.
Per Med. 2014 May;11(3):323-337. doi: 10.2217/pme.14.21.
Epigenetic testing, primarily in the form of DNA methylation analysis, is currently being used in healthcare settings to help identify and manage disease conditions and to develop and select drugs that specifically target epigenetic machinery. Yet, the clinical application of epigenetic analysis is still in its infancy. With a number of large-scale national and international epigenomic consortia projects in progress to identify tissue-specific epigenomes in normal and disease conditions, we are now poised for a new era of understanding disease processes based upon genetic changes that do not involve alterations to the DNA sequence. The developing epigenetic knowledge base will significantly advance the practice of personalized medicine and precision therapeutics. In this article, we provide a primer on the fundamentals of epigenetics with an emphasis on DNA methylation and review the prospective uses of epigenetic testing in advancing healthcare.
表观遗传学检测主要以DNA甲基化分析的形式,目前正在医疗环境中用于帮助识别和管理疾病状况,以及开发和选择专门针对表观遗传机制的药物。然而,表观遗传学分析的临床应用仍处于起步阶段。随着许多大规模的国家和国际表观基因组联盟项目正在进行,以识别正常和疾病状况下的组织特异性表观基因组,我们现在正处于一个基于不涉及DNA序列改变的基因变化来理解疾病过程的新时代的开端。不断发展的表观遗传学知识库将显著推动个性化医疗和精准治疗的实践。在本文中,我们提供了一篇关于表观遗传学基础的入门文章,重点是DNA甲基化,并回顾了表观遗传学检测在推进医疗保健方面的潜在用途。